Change of Name
15 September 2023
Further to the passing of the relevant resolution at the Company's Annual General Meeting, held 6 September 2023, the Company confirms the change of name to Cambridge Nutritional Sciences plc has now taken place and becomes effective on the London Stock Exchange today.
The Company's TIDM has been updated to CNSL, but its ISIN (GB00B1VCP282), SEDOL (B1VCP28) and LEI (2138007U9P4BTZTYIR92) numbers remain unchanged.
Shareholders should also note that their holdings of ordinary shares in the Company will not be affected by the change of name. Furthermore, existing share certificates should be retained as they remain valid for all purposes and new share certificates will not be issued.
AIM nominated advisor name change
The Company also notes that its nominated adviser and broker finnCap Ltd, has changed its name to Cavendish Capital Markets Limited.
Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC)
Jag Grewal, Chief Executive Officer
via Walbrook PR
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited
Tel: 020 7933 8780 or [email protected]
Paul McManus / Lianne Applegarth
Mob: 07980 541 893 / 07584 391 303
Mob: 07502 558 258
About Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC)
Omega (AIM: ODX, to become CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.